Decision Resources Group is dedicated to helping life sciences companies make a positive impact for patients around the world through expert consultation, proprietary data and research, and technology solutions. Every client is a partner to us, and we work hard to help them drive better outcomes, and maximum return on their commercial investments.
Syneos Health™ (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to lifeTM visitSyneosHealth.com.
Aetion is a health care technology company that delivers real-world evidence for life sciences, payers, providers, and regulatory agencies. Founded by two Harvard Medical School faculty members, Aetion informs health care’s most critical decisions — what works best, for whom, and when — to guide treatment development, commercialization, and payment innovation into health care’s modern era.
COTA was founded in 2011 by doctors, engineers, and data scientists to create clarity from fragmented and often-inaccessible real-world data. By using our proprietary technology, advanced analytics and deep expertise to organize complex data, we provide a comprehensive picture of cancer that can be used to advance care and research. We believe that everyone touched by cancer deserves a clear path to care. Together, we can make that vision a reality.
Adelphi Real World: Experts in the generation of real-world data and shaping of real-world evidence. Conducting multi-country real-world observational studies and healthcare database analyses for over 20 years, our services are grounded in the extensive heritage afforded by Adelphi’s proprietary Disease Specific Programmes™ and supported by the expansion of our real-world evidence services. Data has supported over 900 publications in peer-reviewed journals & scientific congresses alongside informing therapy guideline evolution & supporting regulatory submissions
Founded in 2008, Life Image has spent the past 11 years building an interoperable network connecting entities across the entire healthcare ecosystem. It connects over 10,000 U.S. facilities, with 150,000 U.S. providers and 58,000 clinics globally. The network enables access to the accurate, real-time, robust data sets that allow stakeholders to make care decisions based on a single version of the truth, fostering better outcomes while ensuring stakeholders are engaged and satisfied with the healthcare experience.
Boston Health Economics (BHE) brings healthcare analytics within reach. With over two decades of experience, BHE provides novel solutions to allow more than 25 of the world’s largest life science companies, health plans and provider groups to better understand the clinical outcomes and value of various patient care strategies. BHE’s market-leading platform transforms the way analysts from diverse disciplines answer complex and critical questions and make insightful predictions. Analyses executed on the platform have been used in numerous regulatory and reimbursement agency submissions in the US, EU, Russia, China and Australia and more than 110 manuscripts and abstracts. Managing big data, getting results faster, and answering critical business questions has never been easier.
Concerto HealthAI, a SymphonyAI portfolio company, is a next generation Real World Evidence company that partners with the American Society of Clinical Oncology’s CancerLinQ initiative and healthcare providers across the U.S. Concerto HealthAI develops engineered Real-World Data products designed for specific use cases, including post approval studies leading to label modifications and market access initiatives and regulatory submissions. Concerto HealthAI’s engineered datasets are deployed in a clinical cloud environment, with AI metadata, AI Models and AI-enabled applications all aligned to generate “precision evidence” required for high priority use cases.
Komodo Health is on a mission to reduce the global burden of disease through the most comprehensive and actionable Healthcare Map. Our platform enables life science partners to extend the reach of innovative therapies, payers to focus on increasing care quality while reducing cost, and providers to identify and address unmet medical needs in their communities. Learn more by visiting www.komodohealth.com.